Ocugen Price To Sales vs. Number Of Shares Shorted

OCGN Stock  USD 0.85  0.04  4.94%   
Considering Ocugen's profitability and operating efficiency indicators, Ocugen Inc may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Ocugen's ability to earn profits and add value for shareholders.

Ocugen Price To Sales Ratio

22.11

As of the 29th of December 2024, Price To Sales Ratio is likely to drop to 22.11. In addition to that, EV To Sales is likely to drop to 16.99. At this time, Ocugen's Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 29th of December 2024, Total Other Income Expense Net is likely to grow to about 2.9 M, though Operating Income is likely to grow to (62.3 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.620.8834
Way Down
Slightly volatile
For Ocugen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ocugen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ocugen Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ocugen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ocugen Inc over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.19)
Revenue Per Share
0.018
Quarterly Revenue Growth
1.353
Return On Assets
(0.48)
Return On Equity
(1.03)
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ocugen Inc Number Of Shares Shorted vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ocugen's current stock value. Our valuation model uses many indicators to compare Ocugen value to that of its competitors to determine the firm's financial worth.
Ocugen Inc is considered to be number one stock in price to sales category among its peers. It also is considered to be number one stock in number of shares shorted category among its peers making about  1,118,676  of Number Of Shares Shorted per Price To Sales. At this time, Ocugen's Price To Sales Ratio is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ocugen's earnings, one of the primary drivers of an investment's value.

Ocugen Number Of Shares Shorted vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Ocugen

P/S

 = 

MV Per Share

Revenue Per Share

 = 
52.41 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Ocugen

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
58.63 M
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Ocugen Number Of Shares Shorted Comparison

Ocugen is currently under evaluation in number of shares shorted category among its peers.

Ocugen Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Ocugen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Ocugen will eventually generate negative long term returns. The profitability progress is the general direction of Ocugen's change in net profit over the period of time. It can combine multiple indicators of Ocugen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income20 K21 K
Operating Income-65.5 M-62.3 M
Income Before Tax-63.1 M-59.9 M
Total Other Income Expense Net2.5 M2.9 M
Net Loss-63.1 M-59.9 M
Income Tax Expense536.1 K562.9 K
Interest Income14.5 K13.7 K
Net Loss-63.1 M-59.9 M
Non Operating Income Net Other-279 K-265.1 K
Net Loss-73.2 M-69.6 M
Net Interest Income-90.8 K-95.4 K
Change To Netincome13.3 M14 M
Net Loss(0.26)(0.27)
Income Quality 0.98  0.76 
Net Income Per E B T 1.10  1.11 

Ocugen Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ocugen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ocugen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ocugen's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Ocugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Sign In To Macroaxis Now

   

Sign In To Macroaxis

Sign in to explore Macroaxis' wealth optimization platform and fintech modules
All  Next Launch Module

Use Investing Themes to Complement your Ocugen position

In addition to having Ocugen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Munis Funds Thematic Idea Now

Munis Funds
Munis Funds Theme
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:
Check out Your Equity Center.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
To fully project Ocugen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ocugen Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ocugen's income statement, its balance sheet, and the statement of cash flows.
Potential Ocugen investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Ocugen investors may work on each financial statement separately, they are all related. The changes in Ocugen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ocugen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.